Collegium Pharmaceutical, Inc.
- COLL
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Pain Management
- Specialty Pharma
$23.01
Today −0.78%Quote Oct 19, 2026, 08:00 PM UTC
+1.05%over the last month
Max drawdown −6.6%From 1-month high −0.8%3 months −35.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Collegium Pharmaceutical
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions.
Where the money comes from
Q2 2026 revenue $199.9M
- Belbuca$57.7M28.9%
- Xtampza ER$45.0M22.5%
- Nucynta ER$15.7M7.9%
- Nucynta IR$14.4M7.2%
- Symproic$3.0M1.5%
- Other / not reported$64.1M32.1%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
423
Founded
2002
Market value
$749.1M
Quote Oct 19
Floor
$22.90
0.5% below price
Resistance
$23.91
3.9% above price
Price vs analyst targets
12 analysts
Lowest target
$45.00Highest target
$50.00
$45.00Highest target
$50.00
- Price $23.01
- Average target $48.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 109% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COLLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free